Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable AestheticsContributed by: Business WireLogoTagsMedical SuppliesHealthFDAOther HealthGeneral HealthPharmaceuticalRestylane
